While anti-VEGF therapy Avastin is not effective in breast cancer and the use of metformin in breast cancer is still undergoing in several clinical trials focused on obese patients48, these drugs still hold promise to be used in selective obese patient populations. Here, VEGFA is linked to breast cancer.